High-Risk Ewing Sarcoma: It Is Time to Break the Ceiling

被引：4
|
作者：
DuBois, Steven G. [1 ]
Gupta, Abha A. [2 ,3 ]
Palmerini, Emanuela [4 ,5 ]
机构：
[1] Harvard Med Sch, Dana Farber Boston Childrens Canc & Blood Disorde, Boston, MA 02115 USA
[2] Univ Toronto, Hosp Sick Children, Dept Paediat, Toronto, ON, Canada
[3] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] IRCCS Ist Ortoped Rizzoli, Osteoncol Bone & Soft Tissue Sarcomas & Innovat T, Bologna, Italy
[5] Bologna Univ, Bologna, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 21期
关键词：
D O I：
10.1200/JCO.22.00449
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2288 / +
页数：4
相关论文
共 50 条
  • [41] AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH RISK EWING SARCOMA IN CHILDREN
    Song, Eun Sun
    Kim, Bo Kyung
    Hong, Kyung Taek
    Choi, Jung Yoon
    Park, Hyun Jin
    Kang, Hyoung Jin
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 357 - 357
  • [42] High-dose chemotherapy and autologous peripheral blood stem cell transplantation in adult patients with high-risk or advanced Ewing and soft tissue sarcoma
    Engelhardt, M.
    Zeiser, R.
    Ihorst, G.
    Finke, J.
    Mueller, C. I.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2007, 133 (01) : 1 - 11
  • [43] High-dose chemotherapy and autologous peripheral blood stem cell transplantation in adult patients with high-risk or advanced Ewing and soft tissue sarcoma
    M. Engelhardt
    R. Zeiser
    G. Ihorst
    J. Finke
    C. I. Müller
    Journal of Cancer Research and Clinical Oncology, 2007, 133 : 1 - 11
  • [44] High-dose chemotherapy with thiotepa, cyclophosphamide and etoposide in high-risk Ewing sarcoma family tumours paediatric patients: single-centre experience
    Ilari, I.
    De Ioris, M. A.
    Pessolano, R.
    Castellano, A.
    Serra, A.
    Jenkner, A.
    De Sio, L.
    Cozza, R.
    Fidani, P.
    De Laurentis, C.
    Donfrancesco, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S82 - S82
  • [45] Efficacy of add-on treosulfan and melphalan high-dose therapy in patients with high-risk metastatic Ewing sarcoma: Report from the International Ewing 2008R3 trial.
    Dirksen, Uta
    Bhadri, Vivek
    Brichard, Benedicte
    Butterfass-Bahloul, Trude
    Cyprova, Sona
    Faldum, Andreas
    Gelderblom, Hans
    Hardes, Jendrik
    Hauser, Peter
    Havemann, Lianne
    Hjorth, Lars
    Juergens, Heribert
    Kanerva, Jukka
    Kuehne, Thomas
    Ladenstein, Ruth Lydia
    Raciborska, Anna
    Rascon, Jelena
    Timmermann, Beate
    Ranft, Andreas
    Koch, Raphael
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [46] IS IT TIME TO RETHINK HIGH-RISK LABELING
    WHALE, K
    JOURNAL OF CLINICAL PATHOLOGY, 1986, 39 (01) : 114 - 114
  • [47] Radiosensitization in the neoadjuvant Therapy of High-risk Soft tissue sarcoma
    Eckert, F.
    Gani, C.
    Mayer, F.
    Kopp, H. -G
    Kluba, T.
    Bamberg, M.
    Mueller, A. -C
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 104 - 104
  • [48] Adjuvant Therapy for High-Risk Soft Tissue Sarcoma in the Adult
    Gronchi, Alessandro
    Casali, Paolo G.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2013, 14 (03) : 415 - 424
  • [49] Adjuvant Therapy for High-Risk Soft Tissue Sarcoma in the Adult
    Alessandro Gronchi
    Paolo G. Casali
    Current Treatment Options in Oncology, 2013, 14 : 415 - 424
  • [50] Sinusoidal obstruction syndrome;/veno-occlusive disease after high-dose intravenous busulfan;/melphalan conditioning therapy in high-risk Ewing Sarcoma
    Abate, Massimo Eraldo
    Paioli, Anna
    Cammelli, Sivlia
    Cesari, Marilena
    Longhi, Alessandra
    Palmerini, Emanuela
    Ferrari, Stefano
    Carretta, Elisa
    Picci, Piero
    Piscaglia, Fabio
    BONE MARROW TRANSPLANTATION, 2018, 53 (05) : 591 - 599
12345